Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
II 型 JAK2 抑制剂 CHZ868 对 B 细胞急性淋巴细胞白血病的活性
期刊:Cancer Cell
影响因子:48.8
doi:10.1016/j.ccell.2015.06.005
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy van der Zwet, Jacob V Layer, Trevor Tivey, Andrew A Lane, Jeremy A Ryan, Samuel Y Ng, Daniel J DeAngelo, Richard M Stone, David Stee
